PARP1 also exerts context-dependent effects: it promotes apoptosis to eliminate DNA-damaged cells early in tumorigenesis, but excessive activation depletes NAD+ and ATP, triggering parthanatos and inhibiting cancer progression [122]. Here, PARP1 is linked to cancer.